• This record comes from PubMed

Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II

. 2015 May 28 ; 58 (10) : 4357-63. [epub] 20150507

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

We present here a structure-aided design of inhibitors targeting the active site as well as exosites of glutamate carboxypeptidase II (GCPII), a prostate cancer marker, preparing potent and selective inhibitors that are more than 1000-fold more active toward GCPII than its closest human homologue, glutamate carboxypeptidase III (GCPIII). Additionally, we demonstrate that the prepared inhibitor conjugate can be used for sensitive and selective imaging of GCPII in mammalian cells.

References provided by Crossref.org

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...